相关研究结果支撑Target Y成为覆盖多种炎症性和退行性眼病的关键治疗靶点。 (IMAGE)

InSilico Medicine

相关研究结果支撑Target Y成为覆盖多种炎症性和退行性眼病的关键治疗靶点。

Caption

此外，ISM9077还在多个独立葡萄膜炎模型中显著减轻眼底炎症、抑制炎症因子释放并恢复视网膜功能；在干眼模型中则提升泪液分泌、缓解角膜炎症，同时起效快速，其疗效优于当前标准治疗药物环孢素A。

Credit

英矽智能

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.